Stevens-Johnson Syndrome Induced by Vandetanib

Vandetanib is a once-daily oral anticancer drug that selectively inhibits key signaling pathways in cancer by targeting vascular endothelial growth factor receptors, epidermal growth factor receptors tyrosine kinase, and rearranged during transfection-dependent tumor cell proliferation and survival....

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Yoon, Jimi, Oh, Chee Won, Kim, Chi Yeon
Format: Artigo
Jezik:Inglês
Izdano: Korean Dermatological Association; The Korean Society for Investigative Dermatology 2011
Teme:
Case Report
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3276793/
https://ncbi.nlm.nih.gov/pubmed/22346274
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5021/ad.2011.23.S3.S343
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki